Please Wait
Applying Filters...
menu
    • menu
    Strides Pharma Science-PSE
    News
    US FDA approves Mirum Pharma's genetic disorder drug

    22 Feb 2025

    // REUTERS

    Novo's Wegovy and Ozempic removed from US FDA shortage list

    22 Feb 2025

    // REUTERS

    Cosette snaps up Mayne Pharma for $430M

    22 Feb 2025

    // FIERCE PHARMA

    Data Compilation
    #PharmaFlow

    Beltapharm SPA

    Contact Supplier

    Website

    BioAsia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Menu

    Beltapharm SPA

    EVENTS

    • Webinars & Exhibitions

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Beltapharm SPA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    The Generic Rx Session
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    City : Milano

    State :

    Country/Area : IT

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-15

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    The Generic Rx Session
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    City : Milano

    State :

    Country/Area : IT

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Beltapharm SPA

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow